Novel antibacterial drugs developed at University of Eastern Finland
In the era of increased antibiotic resistance, it is necessary to focus on developing new antibacterial agents
Author
Ajanta Pharma’s PAT up 2 per cent in H1 FY 2019
The company's income from operations is at ₹ 1,055 crore against ₹ 1,014 crore
DRL launches Atomoxetine capsules in the US
The capsules are available in 10 mg, 18 mg, 25 mg, 40 mg, 60 mg, 80 mg, 100 mg with 30 counts bottle size
FICCI and US Chamber jointly launch India-US dialogue on IP
Engagement on IP related issues to further strengthen Indo-US partnership
A seminar on 'IP Dialogue: Opportunities for US-India…
Depreciating Indian rupee to offer respite to pharma sector: Ind-Ra
Ind-Ra expects the Indian rupee to continue weakening against the US dollar and, thus, support the top line growth of pharma…
Madras HC stays online sale of medicines
The court directed the Centre to file a counter and posted the matter for further hearing to November 9
Strides Pharma Science to get $20 m funding for consumer healthcare biz
The proposed transaction involves subscribing to the equity capital of Strides Consumer Pvt Ltd India and Strides Global Consumer…
DRL gets eight observations from US FDA
The audit of DRL's formulations manufacturing facility at Duvvada, Visakhapatnam was completed today
Sebi refuses stay on forensic audit of Venmax Drugs
Besides, shares held by VDPLs promoters and directors should not be allowed to be transferred for sale by depositories, the order…
Novartis, Pfizer join forces on potentially lucrative fatty liver disease
The collaboration will help develop combination therapies involving medicines they have been working on separately to treat…